Levine Cancer Institute - Academic Profile

Publications

View All

Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study

Jeremy S. Abramson , M. Lia Palomba , Leo I. Gordon +19 more

2020 The Lancet 2118 citations

Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study

Jesús G. Berdeja , Deepu Madduri , Saad Z. Usmani +33 more

2021 The Lancet 1466 citations

A Review of the Evidence for the Use of Telemedicine Within Stroke Systems of Care

Lee H. Schwamm , Robert G. Holloway , Pierre Amarenco +12 more

The aim of this new statement is to provide a comprehensive and evidence-based review of the scientific data evaluating the use of telemedicine for stroke care delivery and to p...

2009 Stroke 433 citations

Recommendations for the Implementation of Telemedicine Within Stroke Systems of Care

Lee H. Schwamm , Heinrich J. Audebert , Pierre Amarenco +13 more

2009 Stroke 294 citations

Affiliated Researchers

Institution Info

Type: healthcare
Country: US
Publications: 4
Citations: 4,311

External Links

Identifiers

ROR: https://ror.org/0174nh398